Literature DB >> 2041086

Molecular characterization of the vaccinia virus hemagglutinin gene.

C K Brown1, P C Turner, R W Moyer.   

Abstract

The vaccinia virus hemagglutinin (HA) is a glycoprotein found on the plasma membrane of infected cells and the envelope of extracellular virus. Two forms of HA (85 and 68 kDa) are detected by immunoblot analysis. Although hemagglutination activity is only readily detectable late in infection, the 85-kDa HA appears early and accumulates throughout infection, whereas the 68-kDa form appears only late in the cycle. Production of the 68-kDa HA but not the 85-kDa HA was inhibited by either cytosine arabinoside or rifampin. Analysis of HA gene expression reveals a complex pattern of expression. The HA gene is transcribed early to yield a 1.65-kb dicistronic early transcript, consisting of the 945-bp HA open reading frame (ORF) fused to a 453-bp downstream ORF. Transcription from this site initiates 7 bases upstream of the AUG initiating codon of the HA ORF. Due to the discrepancy between the calculated size of the HA protein (33 kDa) and that reported for the unglycosylated HA protein derived from in vitro translation (58 kDa), we placed an early transcription termination signal (TTTTTAT) directly downstream of the 945-bp HA ORF. This led to a reduction in size of the early HA mRNA to 1.2 kb, as expected, but had no effect on the formation of either the 85- or 68-kDa protein. Transcripts originating from the early promoter are found throughout the infection cycle. However, after DNA replication, transcription from a second, late promoter ensues. The transcriptional start site of the late promoter is within a consensus TAAATG sequence located 135 bases upstream of the transcriptional start site of the first promoter. The late transcriptional start site is also found within an upstream ORF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041086      PMCID: PMC241363     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates.

Authors:  R F Weaver; C Weissmann
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

2.  Biogenesis of vaccinia: molecular basis for the hemagglutination-negative phenotype of the IHD-W strain.

Authors:  H Shida; S Dales
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

3.  Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs.

Authors:  J A Cooper; R Wittek; B Moss
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  The white pock mutants of rabbit poxvirus. IV. The late white pock (mu) host range (hr) mutants of rabbit poxvirus are blocked in morphogenesis.

Authors:  R W Moyer; R L Graves
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment.

Authors:  A Mahr; B E Roberts
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

7.  The white pock mutants of rabbit poxvirus. I. Spontaneous host range mutants contain deletions.

Authors:  R W Moyer; C T Rothe
Journal:  Virology       Date:  1980-04-15       Impact factor: 3.616

8.  Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules.

Authors:  H Shida; S Dales
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

9.  Characterization of vaccinia polypeptides.

Authors:  M Oie; Y Ichihashi
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

10.  Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope.

Authors:  H Shida; S Matsumoto
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

View more
  20 in total

1.  An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.

Authors:  Parag Parekh; Zhiwen Tang; Peter C Turner; Richard W Moyer; Weihong Tan
Journal:  Anal Chem       Date:  2010-10-15       Impact factor: 6.986

3.  The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.

Authors:  Amalia K Earley; Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 4.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

5.  Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.

Authors:  Ann Chahroudi; David A Garber; Patrick Reeves; Luzheng Liu; Daniel Kalman; Mark B Feinberg
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.

Authors:  E Katz; E J Wolffe; B Moss
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.

Authors:  Ann Chahroudi; Rahul Chavan; Natalia Kozyr; Natalia Koyzr; Edmund K Waller; Guido Silvestri; Mark B Feinberg
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Myxoma virus encodes an alpha2,3-sialyltransferase that enhances virulence.

Authors:  R J Jackson; D F Hall; P J Kerr
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.

Authors:  Timothy R Wagenaar; Suany Ojeda; Bernard Moss
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.

Authors:  Aodhnait S Fahy; Richard H Clark; Emily F Glyde; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.